Arrivent Biopharma shares owned by UBS Group
Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Arrivent Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Arrivent Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arrivent Biopharma by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $9.1M | 451k | 20.12 |
| 2025-09-30 | $9.2M | 498k | 18.45 |
| 2025-06-30 | $1.9M | 87k | 21.77 |
| 2025-03-31 | $3.7M | 202k | 18.49 |
| 2024-12-31 | $1.9M | 73k | 26.64 |
| 2024-09-30 | $438k | 19k | 23.50 |
| 2024-06-30 | $222k | 12k | 18.55 |
| 2024-03-31 | $177k | 9.9k | 17.86 |